M2 Presswire - Analysis of Forest Laboratories, Inc.
M2 PRESSWIRE-7 February 2007-Biotech News: Analysis of Forest Laboratories, Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07022007 Forest Laboratories doesn’t just blend in with the trees. The company develops and manufactures name-brand as well as generic prescription and over-the-counter pharmaceutical products.
Related Results
Monsanto Issues Warning on Drugs with Similar Names.
Promising Treatment for Hot Flashes Reported in Journal of Palliative Medicine
Panic attacks associated with citalopram.
Novartis advises of changes to Clozaril label.(Adult Psychiatry)
Danish Drug Maker to Acquire Paramus, N.J., Biotechnology Firm.
The company’s central nervous system pharmaceutical line includes antidepressants Celexa and Lexapro, as well as Namenda, which treats Alzheimer’s disease. cozaar. Other products include treatments for irritable bowel syndrome, hypertension, and pain. Forest Laboratories, …
Read the rest of this article with a Free Trial at HighBeam Research.
